<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Surgery and Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Surgery and Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Хирургия и онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="electronic">2949-5857</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75</article-id><article-id pub-id-type="doi">10.17650/2220-3478-2014-0-3-17-22</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">MORPHOLOGICAL ASSESSMENT OF LATERAL EDGE OF A RESECTION AS A FACTOR OF THE FORECAST OF LOCAL RECURRENCE AT A CANCER OF A RECTUM. FORECASTING OF RECURRENCE OF A TUMOR BY MEANS OF AN ASSESSMENT OF MARKERS OF A COLORECTAL CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>МОРФОЛОГИЧЕСКАЯ ОЦЕНКА ЛАТЕРАЛЬНОГО КРАЯ РЕЗЕКЦИИ КАК ФАКТОР ПРОГНОЗА МЕСТНОГО РЕЦИДИВА ПРИ РАКЕ ПРЯМОЙ КИШКИ. ПРОГНОЗИРОВАНИЕ РЕЦИДИВА ОПУХОЛИ С ПОМОЩЬЮ ОЦЕНКИ МАРКЕРОВ КОЛОРЕКТАЛЬНОГО РАКА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Litvinova</surname><given-names>U. A.</given-names></name><name xml:lang="ru"><surname>Литвинова</surname><given-names>У. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>litvinova.u@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Muravyov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Муравьев</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>litvinova.u@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Solovyov</surname><given-names>I. Ye.</given-names></name><name xml:lang="ru"><surname>Соловьев</surname><given-names>И. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>litvinova.u@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Stavropol Regional Clinical Oncology Dispensary</institution></aff><aff><institution xml:lang="ru">ГБУЗ СК «Ставропольский краевой клинический онкологический диспансер», Ставрополь</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">City Clinical Hospital № 2, Stavropol</institution></aff><aff><institution xml:lang="ru">МБУЗ «Городская клиническая больница № 2», Ставрополь</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-09-26" publication-format="electronic"><day>26</day><month>09</month><year>2014</year></pub-date><volume>3</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>17</fpage><lpage>22</lpage><history><date date-type="received" iso-8601-date="2015-02-28"><day>28</day><month>02</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-02-28"><day>28</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Litvinova U.A., Muravyov A.V., Solovyov I.Y.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Литвинова У.А., Муравьев А.В., Соловьев И.Е.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Litvinova U.A., Muravyov A.V., Solovyov I.Y.</copyright-holder><copyright-holder xml:lang="ru">Литвинова У.А., Муравьев А.В., Соловьев И.Е.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://onco-surgery.info/jour/article/view/75">https://onco-surgery.info/jour/article/view/75</self-uri><abstract xml:lang="en"><p>This is a review of the literature on the application of magnetic resonance imaging as a method of preoperative staging of colorectal cancer, total mesorectal excision with pathologic evaluation of the lateral resection margin and the clinical significance of molecular markers of drug therapy.</p></abstract><trans-abstract xml:lang="ru"><p>Представлен обзор литературы, посвященный применению магнитно-резонансной томографии как метода предоперационного стадирования рака прямой кишки, тотальной мезоректумэктомии с морфологической оценкой латерального края резекции и клинической значимости молекулярных маркеров эффективности лекарственной терапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>colorectal cancer</kwd><kwd>total mesorectal excision</kwd><kwd>lateral resection margin</kwd><kwd>molecular marker</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак прямой кишки</kwd><kwd>тотальная мезоректумэктомия</kwd><kwd>латеральный край резекции</kwd><kwd>молекулярные маркеры</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52(2):23–47.</mixed-citation><mixed-citation xml:lang="ru">Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52(2):23–47.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Муравьев А.В., Волостников Е.В., Донцов А.Е. и др. Роль МРТ в стадийной диагностике и планировании лечения рака прямой кишки. Мат. I съезда колопроктологов СНГ. Ташкент, 2009. С. 239–240.</mixed-citation><mixed-citation xml:lang="ru">Муравьев А.В., Волостников Е.В., Донцов А.Е. и др. Роль МРТ в стадийной диагностике и планировании лечения рака прямой кишки. Мат. I съезда колопроктологов СНГ. Ташкент, 2009. С. 239–240.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Dr. Gina Brown Royal Marsden Downs Road Sutton Surrey Staging of rectal cancer: a practical approach. Presented at RSNA 2010 personalized medicine: in Pursuid of Excellence.</mixed-citation><mixed-citation xml:lang="ru">Dr. Gina Brown Royal Marsden Downs Road Sutton Surrey Staging of rectal cancer: a practical approach. Presented at RSNA 2010 personalized medicine: in Pursuid of Excellence.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Steinberg S.M., Barkin J.S., Kaplan R.S., Stablein D.M. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 1986;57(9):1 866–70.</mixed-citation><mixed-citation xml:lang="ru">Steinberg S.M., Barkin J.S., Kaplan R.S., Stablein D.M. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 1986;57(9):1 866–70.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon Lancet 1908;2:1812–3.</mixed-citation><mixed-citation xml:lang="ru">Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon Lancet 1908;2:1812–3.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Morris E., Quirke P., Thomas J.D. et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene. Gut 2008;57(12):1690–7.</mixed-citation><mixed-citation xml:lang="ru">Morris E., Quirke P., Thomas J.D. et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene. Gut 2008;57(12):1690–7.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Williams N.S., Dixon M.E., Johnston D. Reappraisal of the 5-centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients survival. Br J Surg 1983;70(3):150–6.</mixed-citation><mixed-citation xml:lang="ru">Williams N.S., Dixon M.E., Johnston D. Reappraisal of the 5-centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients survival. Br J Surg 1983;70(3):150–6.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Holschneider A.M., Hecker W.C. Reverse smooth muscle plasty: a new method of treating anorectal incontinence in infants with high anal and rectal atresia. J Pediatr Surg 1981;16(6):917–20.</mixed-citation><mixed-citation xml:lang="ru">Holschneider A.M., Hecker W.C. Reverse smooth muscle plasty: a new method of treating anorectal incontinence in infants with high anal and rectal atresia. J Pediatr Surg 1981;16(6):917–20.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg 1982;69(10):613–6.</mixed-citation><mixed-citation xml:lang="ru">Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg 1982;69(10):613–6.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Takahashi T., Ueno M., Azekura K., et al. The lymphatic spread of rectal cancer and the effect of dissection: Japanese contribution and experience. In: Soreide O., Norstein J., eds. Rectal cancer surgery. Berlin: Springer-Verlag, 1997. P. 164–180.</mixed-citation><mixed-citation xml:lang="ru">Takahashi T., Ueno M., Azekura K., et al. The lymphatic spread of rectal cancer and the effect of dissection: Japanese contribution and experience. In: Soreide O., Norstein J., eds. Rectal cancer surgery. Berlin: Springer-Verlag, 1997. P. 164–180.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Compton C.C., Fielding L.P., Burgart L.J. et al. Prognostic factors in colorectal cancer. College of American Patologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124(7):979–94.</mixed-citation><mixed-citation xml:lang="ru">Compton C.C., Fielding L.P., Burgart L.J. et al. Prognostic factors in colorectal cancer. College of American Patologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124(7):979–94.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Quirke P., Durdet P., Dixon M.F., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2(8514):996–9.</mixed-citation><mixed-citation xml:lang="ru">Quirke P., Durdet P., Dixon M.F., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2(8514):996–9.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Allred D.C., Harvey J.M., Berardo M., Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11(2):155–68.</mixed-citation><mixed-citation xml:lang="ru">Allred D.C., Harvey J.M., Berardo M., Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11(2):155–68.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Graziano F., Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes’ B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003;14(7):1026–38.</mixed-citation><mixed-citation xml:lang="ru">Graziano F., Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes’ B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003;14(7):1026–38.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Willett C.G., Warland G., Hagan M.P. et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13(6):1417–24.</mixed-citation><mixed-citation xml:lang="ru">Willett C.G., Warland G., Hagan M.P. et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13(6):1417–24.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Tabuchi Y., Nakamura T., Kuniyasu T. et al. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Surg Today 1999;29(2):116–20.</mixed-citation><mixed-citation xml:lang="ru">Tabuchi Y., Nakamura T., Kuniyasu T. et al. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Surg Today 1999;29(2):116–20.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Choi H.J., Jung I.K., Kim S.S., Hong S.H. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive carcinomas. Dis Colon Rectum 1997;40(1):51–5.</mixed-citation><mixed-citation xml:lang="ru">Choi H.J., Jung I.K., Kim S.S., Hong S.H. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive carcinomas. Dis Colon Rectum 1997;40(1):51–5.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Nakamura M., Miyamoto S., Maeda H. et al. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes’ C human colorectal cancers. Clin Cancer Res 2004;10(24):8434–41.</mixed-citation><mixed-citation xml:lang="ru">Nakamura M., Miyamoto S., Maeda H. et al. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes’ C human colorectal cancers. Clin Cancer Res 2004;10(24):8434–41.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Elder D., Hallstrom M., Johston P.G. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 2000;6:1378–84.</mixed-citation><mixed-citation xml:lang="ru">Elder D., Hallstrom M., Johston P.G. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 2000;6:1378–84.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Cascinu S., Georgoulias V., Kerr D. et al. Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. Ann Oncol 2003;14:25–9.</mixed-citation><mixed-citation xml:lang="ru">Cascinu S., Georgoulias V., Kerr D. et al. Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. Ann Oncol 2003;14:25–9.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Yoshikawa R., Yanagi H., Kusunoki M. et al. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients. Int J Oncol 2002;21(6):1223–8.</mixed-citation><mixed-citation xml:lang="ru">Yoshikawa R., Yanagi H., Kusunoki M. et al. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients. Int J Oncol 2002;21(6):1223–8.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Diez M., Medrano M., Muguerza J.M. et al. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas. Anticancer Res 2000;20(5):3907–12.</mixed-citation><mixed-citation xml:lang="ru">Diez M., Medrano M., Muguerza J.M. et al. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas. Anticancer Res 2000;20(5):3907–12.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
